India's Alembic Pharmaceuticals rises on US FDA's tentative approval for Ivosidenib tablets

Alembic Pharmaceuticals

04/07/2024 08:52

** Shares of Alembic Pharmaceuticals  ALEM.NS  rise as much
as 4.2% to 990.20 rupees
    ** Co gets U.S. FDA's tentative approval for Ivosidenib
tablets used in the treatment of leukemia
    ** Trading vol 1.2x 30-day daily avg
    ** Avg rating of 11 analysts equivalent of "hold", median PT
is 922.50 rupees - LSEG data
    ** Stock fell 11% in June quarter vs gain of 29.7% in March
quarter
    ** Stock last up 2.9%, pushing YTD gains to 28.8%



 (Reporting by Ashish Chandra in Bengaluru)
 ((ashish.chandra@thomsonreuters.com (+91 7982114624))